Avaleht/Aktsiad/NYXH

NYXH

USD

Nyxoah SA Ordinary Shares

$5.870+0.010 (0.171%)

Reaalajas hind

Healthcare

Medical Instruments & Supplies

Belgia

Hinnagraafik

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$5.860

Kõrge

$6.058

Madal

$5.850

Maht

0.00M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

228.1M

Tööstusharu

Medical Instruments & Supplies

Riik

Belgium

Kauplemisstatistika

Keskmine maht

0.13M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $5.55Praegune $5.870Kõrge $12.21

Seotud uudised

22. apr 2025 · 19:58

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

Vaata rohkem

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

21. apr 2025 · 15:19

Analyst Upgrades

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14

Stifel analyst Jonathan Block maintains Nyxoah with a Buy and lowers the price target from $15 to $14.

Vaata rohkem

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14

16. apr 2025 · 06:00

GlobeNewswire

Conditional Issuance of Shares

INSIDE INFORMATIONREGULATED INFORMATION Conditional Issuance of Shares Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"),

Vaata rohkem

14. apr 2025 · 22:19

PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. ("Nyxoah" or the "Company") (NASDAQ: NYXH). Such investors are advised to ...

Vaata rohkem

8. apr 2025 · 13:32

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target

HC Wainwright & Co. analyst Edward White reiterates Nyxoah with a Buy and maintains $15 price target.

Vaata rohkem

HC Wainwright & Co. Reiterates Buy on Nyxoah, Maintains $15 Price Target

GlobeNewswire

8. apr 2025 · 05:00

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Nyxoah Provides Update on FDA Approvable Letter for Genio System Expects to meet final FDA requirements for full PMA approval in the second quarter Mont-Saint-Guibert, Belgium – April 8, 2025, 07:00am CET / 1:00am ET –

PR Newswire

7. apr 2025 · 13:33

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nyxoah S.A....